These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2439532)

  • 1. Villous alpha-fetoprotein in molar and non-molar abortuses.
    Vejerslev LO; Nørgaard-Pedersen B
    Hum Reprod; 1987 Apr; 2(3):237-40. PubMed ID: 2439532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of alpha-fetoprotein-negativity in the interstitial area of total hydatidiform mole tissue].
    Yoshimatsu N; Hoshi K; Sato A; Munakata S; Fukushima T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):918-24. PubMed ID: 2440962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of major histocompatibility (HLA) antigens in chorionic villi of molar pregnancy.
    Berkowitz RS; Anderson DJ; Hunter NJ; Goldstein DP
    Am J Obstet Gynecol; 1983 May; 146(2):221-2. PubMed ID: 6846443
    [No Abstract]   [Full Text] [Related]  

  • 4. Aneuploidy is frequent in heterozygous diploid and triploid hydatidiform moles.
    Walbum P; Andreasen L; Geilswijk M; Niemann I; Sunde L
    Sci Rep; 2024 Mar; 14(1):6876. PubMed ID: 38519579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydatidiform mole: genetic markers in diploid abortuses with macroscopic villous enlargement.
    Vejerslev LO; Dissing J; Hansen HE; Poulsen H
    Cancer Genet Cytogenet; 1987 May; 26(1):143-55. PubMed ID: 3470129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis of molar pregnancy by measuring AFP and HCG in serum (author's transl)].
    Dericks-Tan JS; Taubert HD
    Geburtshilfe Frauenheilkd; 1980 Oct; 40(10):933-5. PubMed ID: 6160078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
    Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
    Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytophotometric DNA determination of trophoblastic neoplasia.
    Nishiya I; Moriya S; Yamashita K; Kikuchi T
    Gynecol Oncol; 1977 Jun; 5(2):103-8. PubMed ID: 195868
    [No Abstract]   [Full Text] [Related]  

  • 10. Presence of immunoreactive luteinizing hormone-releasing factor in hydatidiform mole as compared with normal human trophoblastic tissue.
    Osathanondh R; Elkind-Hirsch KE
    Placenta Suppl; 1981; 3():257-61. PubMed ID: 6763999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic alterations and immunohistochemical analysis of alpha-fetoprotein and CD34 in chorionic villi of anembryonic pregnancy.
    Aydin S; Ozeren M; Yenilmez E; Yulug E; Cobanoglu U; Arvas H
    Saudi Med J; 2006 Feb; 27(2):154-60. PubMed ID: 16501667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal villous morphology mimicking a hydatidiform mole associated with paternal trisomy of chromosomes 3,7,8 and unipaternal disomy of chromosome 11.
    Sebire NJ; May PC; Kaur B; Seckl MJ; Fisher RA
    Diagn Pathol; 2016 Feb; 11():20. PubMed ID: 26846439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in current clinical features of diploid and triploid hydatidiform mole.
    Niemann I; Petersen LK; Hansen ES; Sunde L
    BJOG; 2007 Oct; 114(10):1273-7. PubMed ID: 17655732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
    Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
    Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of alpha-fetoprotein and pregnancy specific beta1 glycoprotein in pregnancies without an embryo.
    Bennett MJ; Grudzinskas JG; Gordon YB; Turnbull AC
    Br J Obstet Gynaecol; 1978 May; 85(5):348-50. PubMed ID: 77162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of alpha-fetoprotein mRNA and protein in human early villous trophoblasts.
    Duc-Goiran P; Mignot TM; Robert B; Machavoine F; Mondon F; Hagneré AM; Vacher-Lavenu MC; Danan JL; Vaiman D; Benassayag C; Ferré F
    Placenta; 2006 Aug; 27(8):812-21. PubMed ID: 16289667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytogenetic, morphological and clinical studies on partial hydatidiform moles].
    Ueda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1071-80. PubMed ID: 4031566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytophotometric DNA-measurements in abortion.
    Kunze WP
    Pathol Res Pract; 1978 Jul; 162(3):253-62. PubMed ID: 683900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydatidiform mole and HLA. II. Compatibility between patient and conceptus.
    Hansen HE; Vejerslev LO; Larsen SO
    Tissue Antigens; 1988 Sep; 32(3):155-61. PubMed ID: 2851196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.
    Sunde L; Lund H; J Sebire N; Grove A; Fisher RA; Niemann I; Kjeldsen E; Andreasen L; Hansen ES; Bojesen A; Bolund L; Nyegaard M
    Medicine (Baltimore); 2015 Nov; 94(44):e1776. PubMed ID: 26554776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.